Education
About Us
Working with TipRanks
Follow Us
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
RESEARCH TOOLSreports
Total Valuation
JCR Pharmaceuticals Co., Ltd. has a market cap or net worth of ¥87.00B. The enterprise value is ¥106.90B.
Market Cap¥87.00B
Enterprise Value¥106.90B
Share Statistics
JCR Pharmaceuticals Co., Ltd. has 129,686,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding129,686,310
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
JCR Pharmaceuticals Co., Ltd.’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -5.76%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-5.76%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee35.41M
Profits Per Employee-5.09M
Employee Count934
Asset Turnover0.32
Inventory Turnover0.53
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio1.59
Price to Fair Value1.27
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio<0.01
Income Statement
In the last 12 months, JCR Pharmaceuticals Co., Ltd. had revenue of 33.07B and earned -4.76B in profits. Earnings per share was -38.43.
Revenue33.07B
Gross Profit21.55B
Operating Income-6.84B
Pretax Income-6.41B
Net Income-4.76B
EBITDA-2.88B
Earnings Per Share (EPS)-38.43
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
JCR Pharmaceuticals Co., Ltd. pays an annual dividend of ¥10, resulting in a dividend yield of 2.81%
Dividend Per Share¥10
Dividend Yield2.81%
Payout Ratio-52.04%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change18.14%
50-Day Moving Average562.06
200-Day Moving Average563.58
Relative Strength Index (RSI)76.65
Average Volume (3m)1.69M
Important Dates
JCR Pharmaceuticals Co., Ltd. upcoming earnings date is Oct 22, 2025, TBA (Confirmed).
Last Earnings DateJul 30, 2025
Next Earnings DateOct 22, 2025
Ex-Dividend DateSep 29, 2025
Financial Position
JCR Pharmaceuticals Co., Ltd. as a current ratio of 1.16, with Debt / Equity ratio of 81.00%
Current Ratio1.16
Quick Ratio0.67
Debt to Market Cap0.64
Net Debt to EBITDA-8.63
Interest Coverage Ratio-44.14
Taxes
In the past 12 months, JCR Pharmaceuticals Co., Ltd. has paid -1.72B in taxes.
Income Tax-1.72B
Effective Tax Rate0.27
Enterprise Valuation
JCR Pharmaceuticals Co., Ltd. EV to EBITDA ratio is -29.41, with an EV/FCF ratio of -5.52.
EV to Sales2.57
EV to EBITDA-29.41
EV to Free Cash Flow-5.52
EV to Operating Cash Flow-15.46
Balance Sheet
JCR Pharmaceuticals Co., Ltd. has ¥15.51B in cash and marketable securities with ¥32.39B in debt, giving a net cash position of ¥16.88B billion.
Cash & Marketable Securities¥15.51B
Total Debt¥32.39B
Net Cash¥16.88B
Net Cash Per Share¥130.15
Tangible Book Value Per Share¥383.10
Margins
Gross margin is 65.29%, with operating margin of -20.69%, and net profit margin of -14.39%.
Gross Margin65.29%
Operating Margin-20.69%
Pretax Margin-19.39%
Net Profit Margin-14.39%
EBITDA Margin-8.72%
EBIT Margin-18.93%
Analyst Forecast
The average price target for JCR Pharmaceuticals Co., Ltd. is ¥576.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥576.67
Price Target Upside-18.89% Downside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-22.86%
EPS Growth Forecast-188.19%